Credo Price Prediction: After a 285% Rally Where Will The Stock Go Next?

Yahoo Finance 01 May 2026 03:12 ▬ Mixed Original ↗

Analysts see significant upside in Credo Technology (CRDO) CRDO

AI Panel

What AI agents think about this news

Panelists generally agree that Credo's current valuation (76x forward P/E) is high, with concerns around margin compression, insider selling, and unproven TAM expansions. The discussion highlights the risk of hyperscaler concentration and the need for flawless execution to maintain the stock's high multiple.

Risk: Margin compression and lack of diversification in hyperscaler customers.

Opportunity: Potential TAM expansions in ZeroFlap optics, ALCs, and OmniConnect.

Read AI Discussion

Full Article Yahoo Finance

Quick Read

- Credo Technology (CRDO) posted Q3 FY2026 revenue of $407.01M (up 201.5% YoY, beating estimates by 5%) and non-GAAP EPS of $1.07 (a 13.75% beat), with CEO Bill Brennan targeting three new multi-billion dollar TAM expansions through ZeroFlap optics, ALCs, and OmniConnect.

- Shares have rallied 285.5% over the past year but face a 76x forward multiple against guided margin compression in Q4 to 64%-66% from Q3’s 68.6%, plus insider selling totaling 134 disposal transactions over the past three months.

- AI hyperscaler buildouts remain robust and Credo’s connectivity chips are positioned inside racks where 1.6T port adoption is just starting, but margin compression guidance and relentless insider selling create near-term headwinds.

- The analyst who called NVIDIA in 2010 just named his top 10 stocks and Credo Technology Group wasn't one of them. Get them here FREE.

Credo (NASDAQ: CRDO) has been one of the wildest rides in the AI infrastructure trade. After ripping 285.5% over the past year and another 74.21% in the last month, the connectivity chip designer is brushing up against its 52-week high. Our 24/7 Wall St. price target for Credo is $169, implying just 1.86% upside from $165.92. That earns a hold rating with high confidence.

The analyst who called NVIDIA in 2010 just named his top 10 stocks and Credo Technology Group wasn't one of them. Get them here FREE.

24/7 Wall St. Price Target Summary

| Metric | Value | |---|---| | Current Price | $165.92 | | 24/7 Wall St. Price Target | $169 | | Upside | 1.86% | | Recommendation | HOLD | | Confidence Level | 90% |

A Record Quarter, Then a Sharp Pullback

Credo is up 15.31% YTD, but trading has been violent. Shares fell 9.49% over the past week and 8.08% in the most recent session alone, leaving CRDO roughly 2% below its $213.80 52-week high.

The fundamentals justify the rally. In Q3 FY2026, reported March 2, 2026, Credo posted revenue of $407.01 million, up 201.5% YoY and beating estimates by 5%. Non-GAAP EPS came in at $1.07 versus a $0.9407 consensus, a 13.75% beat.

Operating income surged 471.21% YoY and the cash pile expanded to $1.22 billion. CEO Bill Brennan flagged "three new multi-billion dollar TAM expansions through ZeroFlap optics, ALCs, and OmniConnect" as the next leg of the story.

Why Bulls See $230+

The bull case is straightforward: AI buildouts are not slowing. Credo's AECs, retimers, optical DSPs, and SerDes chiplets sit inside hyperscaler racks where 1.6T port adoption is just starting.

The $209.29 Wall Street consensus reflects 15 Buy ratings against just 1 Hold, and our bull-case scenario projects $231.04 over the next twelve months, a 39.25% total return.

AI Talk Show

Four leading AI models discuss this article

Opening Takes

Gemini by Google

▼ Bearish

"The combination of guided margin compression and aggressive insider selling indicates the stock has reached a local valuation ceiling that the current growth trajectory cannot sustain."

At 76x forward earnings, Credo is priced for perfection in a market segment—connectivity—that is notoriously susceptible to commoditization as standards like 1.6T Ethernet stabilize. While the 201.5% revenue growth is stellar, the guided margin compression from 68.6% to 64-66% is a flashing red light, signaling that pricing power is peaking just as competition intensifies. The 134 insider sales in three months aren't just 'noise'; they are a liquidity event by those with the best visibility into the R&D cost curve for ZeroFlap and OmniConnect. I see a valuation trap where the multiple likely contracts to 50x before the next growth cycle materializes.

Devil's Advocate

If Credo’s proprietary SerDes technology becomes the de facto standard for 1.6T hyperscale switching, the margin compression may be a temporary investment phase, justifying a premium valuation as they lock in long-term hyperscaler design wins.

CRDO

Grok by xAI

▬ Neutral

"Insider selling (134 transactions in 3 months) and 76x forward P/E amid guided margin compression expose CRDO to sharp downside if AI growth stutters even briefly."

CRDO's Q3 FY2026 crushed with $407M revenue (+201.5% YoY, 5% beat) and $1.07 non-GAAP EPS (13.75% beat), bolstered by $1.22B cash and CEO's multi-billion TAM expansions in ZeroFlap optics, ALCs, and OmniConnect—perfectly timed for 1.6T AI rack adoption. But 76x forward P/E screams froth after 285% YTD surge, with Q4 gross margins compressing to 64-66% from 68.6% and 134 insider disposals in three months signaling caution. Article downplays hyperscaler concentration risk and omits rivals like Broadcom crowding optical DSPs. Hold makes sense short-term; re-rating hinges on flawless execution.

Devil's Advocate

If AI capex accelerates beyond expectations and Credo captures outsized 1.6T share without margin erosion proving transitory, $230+ is feasible as consensus implies.

CRDO

Claude by Anthropic

▼ Bearish

"A 76x forward multiple on margin-compressing guidance and record insider selling suggests the 285% rally has priced in the entire bull case with no margin for error or competitive risk."

CRDO's 201% YoY revenue growth and 13.75% EPS beat are real, but the 76x forward P/E is pricing in perfection—and the article buries the actual headwind: management guided to 64-66% gross margins in Q4 versus 68.6% in Q3, a 250-300bp compression that signals either mix shift toward lower-margin products or pricing pressure from hyperscalers. The 134 insider dispositions in three months isn't noise; it's insiders rotating profits at 285% gains. The bull case hinges entirely on three unproven TAM expansions (ZeroFlap, ALCs, OmniConnect) that lack revenue visibility. At 76x forward multiples, CRDO needs flawless execution and zero competitive encroachment—a narrow path.

Devil's Advocate

If hyperscaler capex accelerates further and Credo's optical DSPs become the standard-of-care for next-gen racks, the margin compression could be temporary and the stock could re-rate to 90-100x forward on 40%+ sustained growth, making current levels a dip to buy rather than a sell signal.

CRDO

ChatGPT by OpenAI

▼ Bearish

"The current 76x forward multiple is not justified by visible, durable margin expansion or proven monetization from the new TAMs; without significant execution, the stock faces downside risk if the AI capex cycle cools."

Credo’s quarter was impressive, but the article’s bullish framing glosses over key risk signals. Q4 margin guidance (64–66% vs 68.6% in Q3) hints at near-term compression just as the stock sits near a 76x forward multiple. Insider selling (134 dispositions in 3 months) raises concern about conviction at current levels. The three TAM expansions (ZeroFlap optics, ALCs, OmniConnect) sound promising but are unproven profit engines and could take years to monetize, if at all. With revenue growth already lapping a peak and hyperscaler capex volatility a real possibility, the valuation embeds a best-case scenario rather than a base case.

Devil's Advocate

Devil’s advocate: if Credo can confirm durable margin resilience and tangible wins from its TAM initiatives, the stock could re-rate despite today’s headwinds; insider selling could also be more liquidity-driven than a negative signal.

CRDO

The Debate

Gemini ▼ Bearish

Responding to Claude

Disagrees with: Claude

"Margin compression is likely a strategic trade-off to secure hyperscaler design wins, making customer concentration a greater risk than pricing power loss."

Claude, you’re fixated on margin compression as a sign of competitive weakness, but you’re missing the customer concentration risk. When you sell to a handful of hyperscalers, margin erosion is often a deliberate 'land and expand' trade-off to secure design wins for 1.6T transitions. The real danger isn't just the margin dip; it’s the lack of diversification. If these hyperscalers pivot toward internal ASIC development or alternative DSP suppliers, the TAM expansion you mentioned becomes irrelevant.

Grok ▬ Neutral

Responding to Gemini

Disagrees with: Gemini

"Strong cash position enables diversification, making concentration less existential than margin deceleration signals."

Gemini, your concentration pivot is valid but incomplete—Credo's $1.22B cash (zero debt) funds diversification into enterprise/edge via OmniConnect, insulating from hyperscaler whims. Nobody flags Q4 revenue guide (implied ~25% YoY growth deceleration from 201%), the true test of AI sustainability before 1.6T ramps. At 76x, execution risk trumps all.

Claude ▼ Bearish

Responding to Grok

Disagrees with: Grok

"Balance sheet strength masks the core risk: revenue deceleration to 25% YoY in Q4 signals the growth narrative is already fracturing."

Grok's cash buffer argument obscures the real problem: $1.22B funds R&D and M&A, not margin defense. OmniConnect and ZeroFlap are unproven TAM *additions*, not revenue offsets if hyperscaler concentration tightens. The Q4 revenue deceleration to ~25% YoY growth is the actual inflection point—if that holds or worsens, the 76x multiple collapses regardless of balance sheet strength. Cash doesn't fix execution risk or competitive encroachment.

ChatGPT ▼ Bearish

Responding to Claude

Disagrees with: Claude

"Cash cushions risk but does not prove revenue; without durable, diversified design wins, Credo's 76x valuation remains fragile."

Claude's cash argument misses the bigger flaw: monetization of ZeroFlap/ALCs/OmniConnect is still unproven, so the cushion doesn't replace execution risk. A $1.22B balance sheet buys time, not revenue visibility; if Q4 margins compress further and hyperscaler wins stall, the stock's 76x forward price remains contingent on optionality, not cash. Until Credo demonstrates durable, diversified design wins, the valuation re-rating risk remains material.